ELKTON, Va.—This story ends down in America’s Deep South, with a report on how a $3.7 billion foreign investment in Alabama that will create thousands of American jobs has sparked vigorous complaints from the US steel industry and the Steelworkers union that it is “unfair.” But it begins quietly on another note here in this pretty little Virginia community (pop. 2,212) nestled in the Shenandoah Valley nearly 100 miles southwest of Washington, D.C. Together, the two otherwise unrelated parts of this article illustrate that while trade liberalization — especially when tariffs are slashed in so-called US Foreign Trade Zones — is clearly beneficial to the US economy, free trade remains politically controversial.
At first glance, Elkton hardly suggests a shining success story that illustrates the benefits of international trade. The deep economic recession has (alas) come to the Blue Ridge mountains; Elkton’s local Chevy Pontiac dealership closed last month, for instance. But business here seems to be great for Merck & Co., the pharmaceutical giant that produces vaccines and medicines in 31 plants in 25 countries. Merck’s sprawling Elkton factory consists of more than 80 buildings that are scattered throughout 1,330 acres out on Route 340 South, about a mile and a half from downtown. It may look nondescript, but this is one of the company’s most important manufacturing locations anywhere. (Just past the plant is a Deer Crossing sign that is riddled with bullet holes, a reminder that folks here in America’s Bible Belt take their guns seriously.)
Merck first set up shop in Elkton in 1941, and now employs some 700 people who make medicines aimed at treating all sorts of evils: HIV, river blindness, Parkinson’s Disease, high cholesterol, glaucoma, and simple pain. There is a $250 million expansion going on, which is expected to add 70 people, possibly many more, to Merck’s roughly $60 million Elkton payroll. The expansion will boost Merck’s production of Gardasil, a cervical cancer vaccine, and is already boosting the fortunes of a long list of workers — some local, others who have come from places like Greenville, South Carolina — who are engaged in the construction: electrical suppliers, painters, carpenters, and so on. If you are looking for a successful American manufacturing plant, this is it.
And if you are looking for an example of how slashing tariffs helps create American jobs by reducing unnecessary costs of production, come to Elkton. Merck pays no US tariffs on the imported raw materials it brings in here through a so-called Foreign Trade Zone. Merck depends upon its duty-free imported chemicals to make its medicines.
So why would Merck executives — the plant manager here in Elkton, Merck’s lobbyists in Washington, D.C., and even one of the company’s official spokeswoman in Merck’s New Jersey headquarters — refuse repeated requests to talk about their success story? If free trade works to enhance your company’s international competitiveness, why not spread the word?
*** Continue reading